MULYE NIRMAL

Director at Synovics Pharmaceuticals · on record since Oct 3, 2006
Chief Scientific Officer at Synovics Pharmaceuticals · on record since Oct 3, 2006
10% owner at Synovics Pharmaceuticals · on record since Oct 3, 2006
10% owner at Cardium Therapeutics, Inc. · on record since Aug 17, 2020

Insider trading activity of MULYE NIRMAL

No transactions on record for MULYE NIRMAL.

Track record of MULYE NIRMAL

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of MULYE NIRMAL

Co-insiders of MULYE NIRMAL

Adams DianeCardium Therapeutics, Inc.
Agrawal NeerajCardium Therapeutics, Inc.
Battery Investment Partners IX, LLCCardium Therapeutics, Inc.
Battery Investment Partners Select Fund I, L.P.Cardium Therapeutics, Inc.
Battery Management Corp.Cardium Therapeutics, Inc.
Battery Partners IX, LLCCardium Therapeutics, Inc.
Battery Partners Select Fund I GP, LLCCardium Therapeutics, Inc.
Battery Partners Select Fund I, L.P.Cardium Therapeutics, Inc.
Battery Ventures IX, L.P.Cardium Therapeutics, Inc.
Battery Ventures Select Fund I, L.P.Cardium Therapeutics, Inc.
BROWN MICHAEL MAURICECardium Therapeutics, Inc.
CHAMBERS JOHN TCardium Therapeutics, Inc.
Coffin-Beach DavidSynovics Pharmaceuticals
Coletta AnthonyCardium Therapeutics, Inc.
Conn Wilson GradCardium Therapeutics, Inc.
Corso JoyCardium Therapeutics, Inc.
Dominguez CarlosCardium Therapeutics, Inc.
Dylan Tyler MichaelCardium Therapeutics, Inc.
Elhafed MoradCardium Therapeutics, Inc.
Feldman JesseCardium Therapeutics, Inc.
FLEISCHER RUSSELL LCardium Therapeutics, Inc.
Gabrielson Edward WCardium Therapeutics, Inc.
GANGE JYOTINDRASynovics Pharmaceuticals
GETRAER STEVENSynovics Pharmaceuticals
GILLIS EDWIN JCardium Therapeutics, Inc.
Gollamudi Raj L.Cardium Therapeutics, Inc.
Grainer James LCardium Therapeutics, Inc.
Griffith William J.G.Cardium Therapeutics, Inc.
Haley Daniel PCardium Therapeutics, Inc.
Harvey Scott MichaelCardium Therapeutics, Inc.
Hauser JanCardium Therapeutics, Inc.
Haverty KevinCardium Therapeutics, Inc.
Hellman & Friedman Capital Partners IX, L.P.Cardium Therapeutics, Inc.
Hellman & Friedman Investors IX, L.P.Cardium Therapeutics, Inc.
H&F Corporate Investors IX, Ltd.Cardium Therapeutics, Inc.
H&F Splash Holdings IX GP, LLCCardium Therapeutics, Inc.
H&F Splash Holdings IX, L.P.Cardium Therapeutics, Inc.
HUTCHISON MURRAY HCardium Therapeutics, Inc.
ICONIQ Strategic Partners-B, L.P.Cardium Therapeutics, Inc.
ICONIQ Strategic Partners GP, L.P.Cardium Therapeutics, Inc.
ICONIQ STRATEGIC PARTNERS II-B, L.P.Cardium Therapeutics, Inc.
ICONIQ Strategic Partners II GP, L.P.Cardium Therapeutics, Inc.
ICONIQ STRATEGIC PARTNERS II, L.P.Cardium Therapeutics, Inc.
ICONIQ Strategic Partners II TT GP, LtdCardium Therapeutics, Inc.
ICONIQ Strategic Partners, L.P.Cardium Therapeutics, Inc.
ICONIQ Strategic Partners TT GP, Ltd.Cardium Therapeutics, Inc.
Jacobson MatthewCardium Therapeutics, Inc.
Jemapete Christopher JCardium Therapeutics, Inc.
Kanouff Yvette MarieCardium Therapeutics, Inc.
KOSSUTH SELWYNCardium Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →